Allarity Therapeutics, Inc.
ALLR
$1.16
$0.08568.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 35.69% | -611.48% | 57.61% | -123.17% | 61.28% |
| Total Depreciation and Amortization | -80.00% | 400.00% | -50.00% | -77.78% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -96.34% | 561.90% | -276.97% | 84.46% | -491.46% |
| Change in Net Operating Assets | 223.76% | 11.72% | -223.79% | -16.96% | 291.52% |
| Cash from Operations | 41.10% | 24.57% | -385.27% | 11.06% | 68.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | 99.71% |
| Issuance of Common Stock | -22.01% | -80.36% | 69,022.50% | -92.35% | -95.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | -- | -- | -- | 100.00% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.00% | -81.50% | 1,806.45% | 164.37% | -91.91% |
| Foreign Exchange rate Adjustments | 273.85% | -13.37% | -167.98% | 404.82% | 12.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 238.96% | -104.07% | 12,859.59% | 111.84% | -225.94% |